Hemophilia Market PPT 2022: Size, Growth, Demand and Forecast till 2027 - PowerPoint PPT Presentation

About This Presentation
Title:

Hemophilia Market PPT 2022: Size, Growth, Demand and Forecast till 2027

Description:

According to the latest research report by IMARC Group, The global hemophilia market reached a value of US$ 10.5 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 20.1 Billion by 2027, exhibiting a CAGR of 11.5% during 2022-2027. More Info:- – PowerPoint PPT presentation

Number of Views:3
Slides: 15
Provided by: MarcelMikaelson
Category:
Tags:

less

Transcript and Presenter's Notes

Title: Hemophilia Market PPT 2022: Size, Growth, Demand and Forecast till 2027


1
Global Hemophilia Market Research and Forecast
Report 2022-2027




Author Elena Anderson Marketing Manager IMARC
Group
2022 IMARC All Rights Reserved
Copyright IMARC Service Pvt Ltd. All Rights
Reserved
2
About IMARC Group
Report Description
International Market Analysis Research and
Consulting Group is a leading adviser on
management strategy and market research
worldwide. We partner with clients in all regions
and industry verticals to identify their
highest-value opportunities, address their most
critical challenges, and transform their
businesses. IMARCs information products include
major market, scientific, economic and
technological developments for business leaders
in pharmaceutical, industrial, and high
technology organizations. Market forecasts and
industry analysis for biotechnology, advanced
materials, chemicals, food and beverage, travel
and tourism, nanotechnology and novel processing
methods are at the top of the companys
expertise. IMARCs tailored approach combines
unfathomable insight into the dynamics of
companies and markets with close cooperation at
all levels of the client organization. This
ensures that our clients achieve unmatchable
competitive advantage, build more proficient
organizations, and secure lasting results.
3
Report Description and Highlights
Report Description
Global Hemophilia Market Research Report
2022-2027 According to the latest report by
IMARC Group, titled "Hemophilia Market Global
Industry Trends, Share, Size, Growth, Opportunity
and Forecast 2022-2027," the global hemophilia
market reached a value of US 10.5 Billion in
2021. Hemophilia refers to a rare bleeding
disorder wherein the blood does not clot
normally, leading to spontaneous or excessive
bleeding even from a minor injury. It is usually
inherited and caused due to a hereditary lack of
a coagulation factor which slows down the blood
clotting process. It is associated with frequent
nosebleeds, easy bruising, hematomas, and
prolonged bleeding or oozing after an injury,
surgery, and dental procedures. In severe cases,
continuous bleeding may also occur following
minor trauma or even in the absence of injury.
Although there is no cure for hemophilia
currently, the condition can be treated using
replacement therapy, medications, and injections
of a clotting factor or plasma. Hemophilia
treatment focuses on replacing the missing
protein and preventing complications, which is
escalating its demand across the globe. Request
for a PDF sample of this report
https//www.imarcgroup.com/hemophilia-market/reque
stsample

4
Report Description and Highlights
Report Description
Global Hemophilia Market Trends The surging
number of hemophilic patients and the rising
incidences of genetic abnormalities represent the
primary factors driving the market growth.
Besides this, the increasing diagnosis rates and
the widespread usage of prophylactic treatment
for hemophilia are other major growth-inducing
factors. Additionally, governing agencies of
various countries are launching campaigns to
spread awareness regarding the benefits of early
diagnosis and taking favorable initiatives to
facilitate the early screening of neonates. In
line with this, due to the limited availability
of treatment options, governments are increasing
support and funding for research and development
(RD) activities to identify therapeutic agents,
which is positively influencing the market
growth. Furthermore, several key players are
focusing on developing technologically advanced
diagnostic tools and therapies to improve the
efficacy and accuracy of hemophilia treatment.
Along with this, extensive investments toward the
establishment of specialized hemophilia treatment
centers (HTC) have catalyzed market growth.
Moreover, the increasing number of organizations,
such as the World Federation of Hemophilia (WFH)
and the National Hemophilia Foundation (NHF),
that aid in discovering treatments for
inheritable bleeding disorders and preventing
complications through education, research, and
advocacy is creating a favorable market outlook.

5
Report Description and Highlights
Report Description
Looking forward, IMARC Group expects the market
to reach US 20.1 Billion by 2027, exhibiting at
a CAGR of 11.5 during 2022-2027. View Report
TOC, Figures and Tables https//www.imarcgroup.co
m/hemophilia-market

6
Report Description and Highlights
Report Description
  • Key Market Segmentation
  • The research report includes the following
    segments
  • Breakup by Type
  • Hemophilia A
  • Hemophilia B
  • Hemophilia C
  • Others
  •  
  • Breakup by Treatment
  • On-Demand
  • Prophylaxis
  • Breakup by Therapy
  • Replacement Therapy
  • ITI Therapy
  • Gene Therapy


7
Report Description and Highlights
Report Description
  •  
  • Breakup by Region
  • North America
  • Asia Pacific
  • Europe
  • Latin America
  • Middle East and Africa
  • Competitive Landscape with Key Players
  • Baxter International Inc
  • Bayer AG
  • BioMarin Pharmaceutical Inc
  • CSL Behring (CSL Limited)
  • F. Hoffmann-La Roche AG
  • Grifols S.A
  • Kedrion S.p.A
  • Novo Nordisk A/S
  • Octapharma AG
  • Pfizer Inc


8
Key Questions Answered in the Report
Report Description
  • How has the global hemophilia market performed so
    far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the
    global hemophilia market?
  • What are the key regional markets?
  • What is the breakup of the market based on the
    type?
  • What is the breakup of the market based on the
    treatment?
  • What is the breakup of the market based on the
    therapy?
  • What are the various stages in the value chain of
    the industry?
  • What are the key driving factors and challenges
    in the industry?
  • What is the structure of the global hemophilia
    market and who are the key players?
  • What is the degree of competition in the
    industry?
  •  

9
Table of Contents
Report Description
1    Preface2    Scope and Methodology    2.1
   Objectives of the Study    2.2  
 Stakeholders    2.3    Data Sources       
2.3.1    Primary Sources        2.3.2  
 Secondary Sources    2.4    Market Estimation 
      2.4.1    Bottom-Up Approach        2.4.2  
 Top-Down Approach    2.5    Forecasting
Methodology3    Executive Summary4  
 Introduction    4.1    Overview    4.2    Key
Industry Trends5    Global Hemophilia Market   
5.1    Market Overview    5.2    Market
Performance    5.3    Impact of COVID-19    5.4
   Market Forecast

10
Table of Contents
Report Description
6    Market Breakup by Type    6.1  
 Hemophilia A        6.1.1 Market Trends       
6.1.2 Market Forecast    6.2    Hemophilia B   
    6.2.1 Market Trends        6.2.2 Market
Forecast    6.3    Hemophilia C        6.3.1
Market Trends        6.3.2 Market Forecast   
6.4    Others        6.4.1 Market Trends       
6.4.2 Market Forecast7    Market Breakup by
Treatment    7.1    On-Demand        7.1.1
Market Trends        7.1.2 Market Forecast     
    Click here to visit the complete table of
content with list of figures and tables
https//www.imarcgroup.com/hemophilia-market/toc

11
Partial List of Clients
We are the trusted business partners to the
world's leading corporates, governments, and
institutions
A partial List of our Clients
12
Partial List of Clients
We are the trusted business partners to the
world's leading corporates, governments, and
institutions
A partial List of our Clients
13
Report Description and Highlights
Report Description

2022 IMARC All Rights Reserved This
Publication and all its contents unless
otherwise mentioned are copyrighted in the name
of International Market Analysis Research and
Consulting (IMARC). No part of this publication
may be reproduced, repackaged, redistributed or
resold in whole or in any part. The publication
may also not be used in any form or by and means
graphic electronic or mechanical, including
photocopying, recording, taping or by information
storage or retrieval, or by any other form,
without the express consent of International
Market Analysis Research and Consulting
(IMARC). Disclaimer All contents and data of
this publication, including forecasts, data
analysis and opinion have been based on
information and sources believed to be accurate
and reliable at the time of publishing.
International Market Analysis Research and
Consulting makes no representation of warranty of
any kind as to the accuracy or completeness of
any Information provided. IMARC accepts no
liability whatsoever for any loss or damage
resulting from opinion, errors or inaccuracies if
any found this publication. IMARC, IMARC Group
and Global Therapy Insight Series are registered
trademarks of International Market Analysis
Research and Consulting. All other trademarks
used in this publication are registered
trademarks of their respective companies.
14

Contact Us
Write a Comment
User Comments (0)
About PowerShow.com